Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001897612-25-000546·Jasper Therapeutics, Inc.
Schedule 13G ownership disclosure
JASPER THERAPEUTICS INC
COMMON STOCK · CUSIP: 471871202
Event date: 2025-09-30
- Filing-level shares
- 2,057,612
- Percent of class
- 7.1%
- T. Rowe Price Investment Management, Inc.
Shares: 2,057,612 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000546
- Form type
- SCHEDULE 13G
- Filer
- Jasper Therapeutics, Inc.
- CIK
- CIK 1788028
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership